Xylocor
4 known investors
XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage. The company's lead program, XC001, targets refractory angina in patients with limited treatment options.
BiotechHealthtechMedical Devices
Founders & leadership
JT
John TuckerPresident and Chief Executive Officer
RC
Ronald CrystalCo-founder
TR
Todd RosengartCo-founder